Exome sequencing in over 63,000 patients in TIMI trials uncovers pathogenic cardiomyopathy variant carriers with high risk for heart failure and cardiovascular death

2 September 2024 (14:05 - 14:15)
Organised by: Logo
Congress Presentation Part of: Probing deeper into the pathophysiology of heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology